Novel Approach To Drug Insolubility Strengthens PolyTherics

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Clinical Trials News
Reply to topic
Novel Approach To Drug Insolubility Strengthens PolyTherics
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Post Posted: Wed May 28, 2008 9:58 pm Reply with quote
Polytherics Ltd ("PolyTherics"), a biopharmaceutical spin-out company from Imperial College London and the London School of Pharmacy that specialises in the targeted application of polymers to biopharmaceuticals, announced the grant of a European patent on the application of polymer complexation technology to improve drug efficacy.

Read more...
View user's profileSend private message
Novel Approach To Drug Insolubility Strengthens PolyTherics
All times are GMT - 7 Hours  
Page 1 of 1  
  
  
Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Clinical Trials News
 Reply to topic  
Forum Map
Site Map